EMPAYES-M
- Manufacturer: Kelps Healthcare Private Limited
- Category: Cardiac & Diabetic, KELPS
- Pack Size: 10*10 BLISTER
- Availability: 10
Product Details
HSN
30049099
EMPAYES-M (Empagliflozin + Metformin)
MOA
- Empagliflozin increases glucose excretion
- Metformin reduces glucose production
- Improves insulin sensitivity
- Lowers blood glucose
- Promotes weight control
- Reduces cardiovascular risk
- Improves metabolic profile
Uses
- Type 2 diabetes
- Poor glycemic control
- Combination therapy
- Obese diabetics
- Cardiovascular protection
- Long-term glucose control
- Metabolic syndrome
Side Effects
- GI upset
- Urinary infections
- Dehydration
- Nausea
- Diarrhea
- Dizziness
- Lactic acidosis (rare)
Precautions
- Take with meals
- Monitor kidney function
- Maintain hydration
- Avoid alcohol
- Monitor blood sugar
- Avoid in severe renal disease
- Use under supervision